AGO2 and osteosarcoma: Further experiments revealed that nuclear miR‐1246 accelerated MNNG cell migration through upregulating migration genes via targeting its enhancers dependent on the AGO2 protein, highlighting the therapeutic potential of miR‐1246 for osteosarcoma.